In this work, we present an account of experimental studies performed for the synthesis, shelf stability andin vitrostability of microbubbles made from perfluorobutane (PFB) gas and coated in a shell of Bovine Serum Albumin (BSA).
Microbubble translations driven by ultrasound-induced radiation forces can be beneficial for applications in ultrasound molecular imaging and drug delivery. Here, the effect of size range in microbubble populations on their translations is investigated experimentally and theoretically. The displacements within five distinct size-isolated microbubble populations are driven by a standard ultrasound-imaging probe at frequencies ranging from 3 to 7 MHz, and measured using the multi-gate spectral Doppler approach. Peak microbubble displacements, reaching up to 10 µm per pulse, are found to describe transient phenomena from the resonant proportion of each bubble population. The overall trend of the statistical behavior of the bubble displacements, quantified by the total number of identified displacements, reveals significant differences between the bubble populations as a function of the transmission frequency. A good agreement is found between the experiments and theory that includes a model parameter fit, which is further supported by separate measurements of individual microbubbles to characterize the viscoelasticity of their stabilizing lipid shell. These findings may help to tune the microbubble size distribution and ultrasound transmission parameters to optimize the radiation-force translations. They also demonstrate a simple technique to characterize the microbubble shell viscosity, the fitted model parameter, from freely floating microbubble populations using a standard ultrasound-imaging probe.
The major bottleneck in the current
chemotherapy treatment of cancer
is the low bioavailability and high cytotoxicity. Targeted delivery
of drug to the cancer cells can reduce the cytotoxicity and increase
the bioavailability. In this context, microbubbles are currently being
explored as drug-delivery vehicles to effectively deliver drug to
the tumors or cancerous cells. Microbubbles when used along with ultrasound
can enhance drug uptake and inhibit the growth of tumor cells. Several
potential anticancer molecules exhibit poor water solubility, which
limits their use in therapeutic applications. Such poorly water soluble
molecules can be coadministered with microbubbles or encapsulated
within or loaded on the microbubbles surface, to enhance the effectiveness
of these molecules against cancer cells. Curcumin is one of such potential
anticancer molecules obtained from the rhizome of herbal spice, turmeric.
In this work, curcumin-loaded protein microbubbles were synthesized
and examined for effective in vitro delivery of curcumin to HeLa cells.
Microbubbles in the size range of 1–10 μm were produced
using perfluorobutane as core gas and bovine serum albumin (BSA) as
shell material and were loaded with curcumin. The amount of curcumin
loaded on the microbubble surface was estimated using UV–vis
spectroscopy, and the average curcumin loading was found to be ∼54
μM/108 microbubbles. Kinetics of in vitro curcumin
release from microbubble surface was also estimated, where a 4-fold
increase in the rate of curcumin release was obtained in the presence
of ultrasound. Sonication and incubation of HeLa cells with curcumin-loaded
BSA microbubbles enhanced the uptake of curcumin by ∼250 times.
Further, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
assay confirmed ∼71% decrease in cell viability when HeLa cells
were sonicated with curcumin-loaded microbubbles and incubated for
48 h.
Type 1 diabetes (T1D) results from immune infiltration and destruction of insulin-producing β cells within the pancreatic islets of Langerhans (insulitis). Early diagnosis during presymptomatic T1D would allow for therapeutic intervention prior to substantial β-cell loss at onset. There are limited methods to track the progression of insulitis and β-cell mass decline. During insulitis, the islet microvasculature increases permeability, such that submicron-sized particles can extravasate and accumulate within the islet microenvironment. Ultrasound is a widely deployable and cost-effective clinical imaging modality. However, conventional microbubble contrast agents are restricted to the vasculature. Submicron nanodroplet (ND) phase-change agents can be vaporized into micron-sized bubbles, serving as a microbubble precursor. We tested whether NDs extravasate into the immune-infiltrated islet microenvironment. We performed ultrasound contrast-imaging following ND infusion in nonobese diabetic (NOD) mice and NOD;Rag1ko controls and tracked diabetes development. We measured the biodistribution of fluorescently labeled NDs, with histological analysis of insulitis. Ultrasound contrast signal was elevated in the pancreas of 10-wk-old NOD mice following ND infusion and vaporization but was absent in both the noninfiltrated kidney of NOD mice and the pancreas of Rag1ko controls. High-contrast elevation also correlated with rapid diabetes onset. Elevated contrast was also observed as early as 4 wk, prior to mouse insulin autoantibody detection. In the pancreata of NOD mice, infiltrated islets and nearby exocrine tissue were selectively labeled with fluorescent NDs. Thus, contrast ultrasound imaging with ND phase-change agents can detect insulitis prior to diabetes onset. This will be important for monitoring disease progression, to guide and assess preventative therapeutic interventions for T1D.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.